阿尼卡医疗 内部交易概览
暂无关于该公司的高管股东内部交易数据
暂无关于该公司18月以内的内部交易数据
阿尼卡医疗 内部交易
阿尼卡医疗 最新内部交易
David Colleran | EVP, General Counsel, Corp Sec | 2022-05-11 | 买入 | 1,500 | 9,867 |
$21.37
|
+29.11%
|
David Colleran | EVP, General Counsel, Corp Sec | 2022-03-14 | 买入 | 1,500 | 8,367 |
$26.65
|
+3.53%
|
Cheryl R Blanchard | President, CEO, Director | 2022-03-11 | 买入 | 8,100 | 59,992 |
$25.57
|
+7.90%
|
Michael L Levitz | EVP, CFO, Treasurer | 2022-03-11 | 买入 | 4,000 | 15,924 |
$24.62
|
+12.06%
|
Michael L Levitz | EVP, CFO, Treasurer | 2021-08-12 | 买入 | 3,627 | 7,486 |
$40.21
|
-31.39%
|
Henneman John B Iii | 董事 | 2021-05-18 | 买入 | 2,000 | 11,310 |
$42.86
|
-35.63%
|
Raymond J Land | 董事 | 2020-11-10 | 卖出 | 3,446 | 9,953 |
$36.77
|
-24.97%
|
James Loerop | EVP Business Development | 2020-07-09 | 卖出 | 1,244 | 1,756 |
$35.15
|
-21.51%
|
Raymond J Land | 董事 | 2020-02-26 | 卖出 | 2,700 | 13,399 |
$42.68
|
-35.36%
|
Sylvia Cheung | CFO | 2019-11-08 | 卖出 | 20,000 | 47,741 |
$59.71
|
-53.79%
|